$CMRX
CHIMERIX INC

2023 Q3 Form 10-Q Financial Statement

#000111748023000024 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $11.00K $26.00K
YoY Change -99.97% -94.09%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $11.00K $26.00K
YoY Change -99.97% -94.09%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $9.300M $4.448M
YoY Change 75.04% -23.84%
% of Gross Profit 84545.45% 17107.69%
Research & Development $17.40M $16.93M
YoY Change 13.97% -6.21%
% of Gross Profit 158145.45% 65100.0%
Depreciation & Amortization $20.00K $23.00K
YoY Change -20.0% -4.17%
% of Gross Profit 181.82% 88.46%
Operating Expenses $26.70M $21.37M
YoY Change 29.76% -10.52%
Operating Profit -$26.69M -$21.35M
YoY Change -329.17% -8.95%
Interest Expense $2.700M $2.772M
YoY Change 1256.78% -13300.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$23.99M -$18.58M
YoY Change -109.93% -20.85%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$23.99M -$18.58M
YoY Change -109.94% -20.85%
Net Earnings / Revenue -218054.55% -71446.15%
Basic Earnings Per Share -$0.27 -$0.21
Diluted Earnings Per Share -$0.27 -$0.21
COMMON SHARES
Basic Shares Outstanding 88.58M shares 88.58M shares
Diluted Shares Outstanding 88.62M shares 88.58M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.5M $205.8M
YoY Change -31.67% 380.84%
Cash & Equivalents $14.12M $20.10M
Short-Term Investments $180.4M $185.7M
Other Short-Term Assets $6.100M $5.735M
YoY Change 1.3% 48.85%
Inventory
Prepaid Expenses
Receivables $11.00K $26.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $200.6M $211.5M
YoY Change -31.09% 316.62%
LONG-TERM ASSETS
Property, Plant & Equipment $248.0K $1.984M
YoY Change -1.59% 867.8%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $22.50M $27.26M
YoY Change
Other Assets $292.0K $326.0K
YoY Change -32.09% -18.3%
Total Long-Term Assets $24.66M $29.57M
YoY Change 793.48% 958.65%
TOTAL ASSETS
Total Short-Term Assets $200.6M $211.5M
Total Long-Term Assets $24.66M $29.57M
Total Assets $225.3M $241.1M
YoY Change -23.34% 350.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.502M $1.823M
YoY Change -23.77% 4.59%
Accrued Expenses $13.01M $13.52M
YoY Change -9.84% -18.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $15.51M $15.34M
YoY Change -12.42% -34.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.500M $1.632M
YoY Change -32.37% -30.96%
Total Long-Term Liabilities $1.500M $1.632M
YoY Change -32.37% -30.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.51M $15.34M
Total Long-Term Liabilities $1.500M $1.632M
Total Liabilities $16.98M $16.97M
YoY Change -14.8% -33.79%
SHAREHOLDERS EQUITY
Retained Earnings -$777.4M -$753.4M
YoY Change 12.26% -19.32%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $208.3M $224.1M
YoY Change
Total Liabilities & Shareholders Equity $225.3M $241.1M
YoY Change -23.34% 350.1%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$23.99M -$18.58M
YoY Change -109.94% -20.85%
Depreciation, Depletion And Amortization $20.00K $23.00K
YoY Change -20.0% -4.17%
Cash From Operating Activities -$17.93M -$14.34M
YoY Change -351.54% 35.81%
INVESTING ACTIVITIES
Capital Expenditures $20.00K $12.00K
YoY Change -127.78%
Acquisitions
YoY Change
Other Investing Activities $11.89M $18.53M
YoY Change -95.01% 176.61%
Cash From Investing Activities $11.87M $18.52M
YoY Change -95.02% 176.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 80.00K -31.00K
YoY Change -89.72% 181.82%
NET CHANGE
Cash From Operating Activities -17.93M -14.34M
Cash From Investing Activities 11.87M 18.52M
Cash From Financing Activities 80.00K -31.00K
Net Change In Cash -5.980M 4.148M
YoY Change -102.43% -207.16%
FREE CASH FLOW
Cash From Operating Activities -$17.93M -$14.34M
Capital Expenditures $20.00K $12.00K
Free Cash Flow -$17.95M -$14.35M
YoY Change -349.31% 35.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
114000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
26000 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
440000 usd
us-gaap Gross Profit
GrossProfit
309000 usd
us-gaap Gross Profit
GrossProfit
341000 usd
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
16926000 usd
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18047000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
35748000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
37087000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4448000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5840000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10127000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11472000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
21374000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
23887000 usd
us-gaap Operating Expenses
OperatingExpenses
45875000 usd
us-gaap Operating Expenses
OperatingExpenses
48559000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21348000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23447000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-45566000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-48218000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2772000 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5618000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-17000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18576000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23468000 usd
us-gaap Net Income Loss
NetIncomeLoss
-39948000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48235000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-476000 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-47000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19158000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23463000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40424000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48282000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88583567 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88583567 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87436180 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87436180 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
88439894 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88439894 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87263452 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
87263452 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
256857000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4363000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
357000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
106000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21372000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21266000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-582000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18576000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19158000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
224112000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
68252000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3708000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
102000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
555000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-52000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-24767000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24819000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
47798000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3593000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-23468000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23463000 usd
us-gaap Net Income Loss
NetIncomeLoss
-39948000 usd
us-gaap Net Income Loss
NetIncomeLoss
-48235000 usd
us-gaap Depreciation
Depreciation
45000 usd
us-gaap Depreciation
Depreciation
48000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
132000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4002000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-74000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7324000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7301000 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1000 usd
cmrx Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent
OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent
-43000 usd
cmrx Operating Lease Right Of Use Asset Amortization Expense And Straight Line Rent
OperatingLeaseRightOfUseAssetAmortizationExpenseAndStraightLineRent
46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1014000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1365000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4019000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-917000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5108000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7108000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36567000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34007000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
30347000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5258000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
15208000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
7699000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
76285000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
57726000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30656000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60167000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
356000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
556000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
188000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
129000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-14000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
168000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13471000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5743000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12689000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25842000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15397000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20099000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28086000 usd
CY2022Q3 cmrx Employee Retention Credit
EmployeeRetentionCredit
2000000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
27000 usd
CY2023Q2 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
7591000 usd
CY2022Q4 cmrx Accrued Development Liabilities
AccruedDevelopmentLiabilities
6691000 usd
CY2023Q2 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
3649000 usd
CY2022Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
6438000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2278000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4252000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13518000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17381000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. In addition to estimates discussed in other sections of this Quarterly Report on Form 10-Q, the most significant estimates in the Company’s consolidated financial statements relate to the valuation of stock options and the valuation allowance for deferred tax assets resulting from net operating losses. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2023Q2 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
213728000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
817000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
212915000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
240455000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
47000 usd
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
384000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
240118000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
187720000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
818000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
187720000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
818000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
60 security
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
60 security
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
179254000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
384000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
179254000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
384000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
55 security
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 security
CY2022Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
55 security
CY2023Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
185657000 usd
CY2023Q2 cmrx Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo
27258000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
212915000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M2D
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
100000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0789
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1728000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
607000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1507000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2114000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
371000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
759000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
781000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
467000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2378000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
264000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2114000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
781000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
467000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2743000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
351000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2392000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
200000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
400000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
300000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
221000 shares
CY2022Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
0 shares
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
134000 shares
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2959000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3593000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7324000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7301000 usd
CY2022 us-gaap Severance Costs1
SeveranceCosts1
400000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
600000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022 cmrx Contract Close Out Costs
ContractCloseOutCosts
799000 usd
CY2022Q2 cmrx Contract Close Out Liability
ContractCloseOutLiability
4539000 usd
cmrx Contract Close Out Liability Adjustments
ContractCloseOutLiabilityAdjustments
-746000 usd
cmrx Contract Close Out Liability Payments
ContractCloseOutLiabilityPayments
2482000 usd
CY2022Q4 cmrx Contract Close Out Liability
ContractCloseOutLiability
1311000 usd
CY2022Q4 cmrx Contract Close Out Liability
ContractCloseOutLiability
1311000 usd
CY2023Q1 cmrx Contract Close Out Liability Adjustments
ContractCloseOutLiabilityAdjustments
10000 usd
CY2023Q1 cmrx Contract Close Out Liability Payments
ContractCloseOutLiabilityPayments
250000 usd
CY2023Q1 cmrx Contract Close Out Liability
ContractCloseOutLiability
1071000 usd
CY2023Q2 cmrx Contract Close Out Liability Adjustments
ContractCloseOutLiabilityAdjustments
-122000 usd
CY2023Q2 cmrx Contract Close Out Liability Payments
ContractCloseOutLiabilityPayments
96000 usd
CY2023Q2 cmrx Contract Close Out Liability
ContractCloseOutLiability
853000 usd
CY2023Q2 cmrx Contract Close Out Liability Adjustments
ContractCloseOutLiabilityAdjustments
-122000 usd
cmrx Contract Close Out Liability Adjustments
ContractCloseOutLiabilityAdjustments
-111000 usd
CY2022Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
20 employee
CY2022Q4 us-gaap Severance Costs1
SeveranceCosts1
1900000 usd
CY2022Q4 cmrx Anticipated Severance Cost
AnticipatedSeveranceCost
1000000 usd
CY2022 us-gaap Severance Costs1
SeveranceCosts1
400000 usd
CY2022Q4 us-gaap Severance Costs1
SeveranceCosts1
1854000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
1442000 usd
CY2023Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-73000 usd
CY2023Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
641000 usd
CY2023Q1 us-gaap Restructuring Reserve
RestructuringReserve
728000 usd
CY2023Q2 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-89000 usd
CY2023Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
395000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
244000 usd

Files In Submission

Name View Source Status
0001117480-23-000024-index-headers.html Edgar Link pending
0001117480-23-000024-index.html Edgar Link pending
0001117480-23-000024.txt Edgar Link pending
0001117480-23-000024-xbrl.zip Edgar Link pending
a20230630cmrxex-311.htm Edgar Link pending
a20230630cmrxex-321.htm Edgar Link pending
cmrx-20230630.htm Edgar Link pending
cmrx-20230630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
cmrx-20230630_def.xml Edgar Link unprocessable
cmrx-20230630_lab.xml Edgar Link unprocessable
cmrx-20230630_pre.xml Edgar Link unprocessable
cmrx-20230630_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cmrx-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable